Centanafadine Shows Positive Results in ADHD Patients with Comorbid Anxiety

Otsuka's experimental ADHD drug, centanafadine, has reported favorable outcomes from its Phase IIIb trial. The study indicated significant improvements in ADHD symptoms for adults also experiencing anxiety. This first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor is currently awaiting review by the U.S. FDA.